Crude extract of hydatid laminated layer from Echinococcus granulosus cyst attenuates mucosal intestinal damage and inflammatory responses in Dextran Sulfate Sodium induced colitis in mice

Journal of Inflammation (United Kingdom)

Volumn 12, Issue 1, 2015, Pages

  Soufli, Imene ^a   Toumi, Ryma ^a   Rafa, Hayet ^a   Amri, Manel ^a   Labsi, Moussa ^a   Khelifi, Lila ^a   Nicoletti, Ferdinando ^b   Touil Boukoffa, Chafia ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Echinococcus granulosus; Experimental colitis; helminth; hydatid laminated layer; Inducible nitric oxide synthase (iNOS); Inflammatory bowel disease (IBD); Interferon (IFN) ; Nitric oxide (NO); Nuclear factor B; tumor necrosis factor (TNF)

Indexed keywords

ANTIINFLAMMATORY AGENT; ECHINOCOCCUS GRANULOSUS LAMINATED LAYER EXTRACT; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ACTIVITY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; ECHINOCOCCUS GRANULOSUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GOBLET CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; INFLAMMATION; INTESTINE INJURY; MOUSE; MUCUS SECRETION; NONHUMAN; PROTEIN EXPRESSION; SURVIVAL RATE;

ECHINOCOCCUS GRANULOSUS; MUS; VERMES;

EID: 84926460666     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-015-0063-6     Document Type: Article

References (38)

1. Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3:390-407.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nat. 2007;448:427-34.
3. Abraham C, Ruslan M. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterol. 2011;140:1729-37. doi:10.1053/j.gastro.2011.02.012.
4. Dijkstra G, Moshage H, Van Dullemen HM, de Jager-Krikken A, Tiebosch AT, Kleibeuker JH, et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol. 1998;86:416-21.
5. Kolios G, Brown Z, Robson RL, Robertson DA, Westwick J. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol. 1995;116:2866-72.
6. Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, et al. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease. Dig Dis Sci. 1997;42:1047-54.
7. Rafa H, Amri M, Saoula H, Belkhelfa M, Medjeber O, Boutaleb A, et al. Involvement of interferon-γ in bowel disease pathogenesis by nitric oxide pathway: a study in algerian patients. J Interferon Cytokine Res. 2010;30:691-7.
8. Abdelouhab K, Rafa H, Toumi R, Bouaziz S, Medjeber O, Touil-Boukoffa C. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebiotics. Immunopharmacol Immunotoxicol. 2011;34:590-7. doi:10.3109/08923973.2011.641971.
9. Toumi R, Abdelouhab K, Rafa H, Soufli I, Raissi-Kerboua D, Djeraba Z, et al. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis. Immunopharmacol Immunotoxicol. 2013;35:403-9. doi:10.3109/08923973.2013.790413.
10. Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterol. 2004;126:1504-17.
11. Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis. 2009;15:128-33. doi:10.1002/ibd.20633.
12. Laclotte C, Oussalah A, Rey P, Bensenane M, Pluvinage N, Chevaux JB, et al. Helminths and inflammatory bowel diseases. Gastroenterol Clin Biol. 2008;32:1064-74. doi: 10.1016/j.gcb.2008.04.030.
13. Sutton TL, Zhao A, Madden KB, Elfrey JE, Tuft BA, Sullivan CA, et al. Antiinflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model. Infect Immun. 2008;76:4772-82. doi:10.1128/IAI.00744-07.
14. Melon A, Wang A, Phan V, McKay DM. Infection with Hymenolepis diminuta is more effective than daily corticosteroids in blocking chemically induced colitis in mice. Biomed Biotechnol. 2009;2010:384523. doi:10.1155/2010/384523.
15. Khan WI, Blennerhasset PA, Varghese AK, Chowdhury SK, Omsted P, Deng Y, et al. Intestinal nematode infection ameliorates experimental colitis in mice. Infect Immun. 2002;70:5931-7.
16. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol. 2004;34:2690-8.
17. Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban Jr JF, et al. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol-Gastrointest Liver Physiol. 2003;284:385-91.
18. Smith P, Mangan NE, Walsh CM, Fallon RE, McKenzie AN, Van Rooijen N, et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol. 2007;178:4557-66.
19. Summers RW, Elliott DE, Urban Jr JF, Thompson RA, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut. 2005;54:87-90.
20. Summers RW, Elliott DE, Urban Jr JF, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterol. 2005;128:825-32.
21. Garg SK, Croft AM, Bager P. Helminth therapy (worms) for induction of remission in inflammatory bowel disease. Cochrane Database Syst Rev. 2014;20(1):CD009400. doi:10.1002/14651858.
22. Touil-boukoffa C, Sancëau J, Tayebi B, Wietzerbin J. Relationship among circulating interferon, tumor necrosis factor-α, and interleukin-6 and serologic reaction against parasitic antigen in human hydatidosis. J Interferon Cytokine Res. 1997;17:211-7.
23. Diaz A, Casaravilla C, Irigoin F, Lin G, Previato J, Fernando F. Understanding the laminated layer of larval Echinococcus I: structure. Trends Parasitol. 2011;27:204-13. doi:10.1016/j.pt.2010.12.012.
24. Steers NJR, Rogan MT, Heath S. In-vitro susceptibility of hydatid cysts of Echinococcus granulosus to nitric oxide and the effect of the laminated layer on nitric oxide production. Parasite Immunol. 2001;23:411-7.
25. Andrade MA, Siles-Lucas M, Espinoza E, Arellano JLP, Gottstein B, Muro A. Echinococcus multilocularis laminated-layer components and the E14t 14-3-3 recombinant protein decrease NO production by activated rat macrophages in vitro. Nitric Oxide. 2004;10:150-5.
26. Siracusano A, Delunardo F, Teggi A, Ortona E. Host-parasite relationship in cystic echinococcosis: an evolving story. Clin Dev Immunol. 2011;2012:639362. doi:10.1155/2012/639362.
27. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya RA. Novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterol. 1990;98:694-702.
28. Cooper HS, Murthy SN, Shah RS, Sedergran SJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238-49.
29. Messaoudene D, Belguendouz H, Ahmedi ML, Benabdekader T, Otmani F, Terahi M, et al. Ex vivo effects of flavonoïds extracted from Artemisia herba alba on cytokines and nitric oxide production in Algerian patients with Adamantiades-Behçet's disease. J inflamm (Lond). 2011;21:35. doi:10.1186/1476-9255-8-35.
30. Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production. Am J Physiol Regul Integr Comp Physiol. 2001;281:1264-73.
31. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114:385-91.
32. Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferongamma (IFN-γ)-and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol. 1999;116:238-45.
33. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut. 1995;36:718-23.
34. Saura M, Zaragoza C, Clare B, McMillan A, Lowenstein CJ. Interaction of interferon regulatory factor-1 and nuclear factor kB during activation of inducible nitric oxide synthase transcription. J Mol Biol. 1999;289:459-71.
35. Cheshire JL, Baldwin AS. Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation. Mol Cell Biol. 1997;17:6746-54.
36. Schottelius AJG, Baldwin Jr AS. A role for transcription factor NF-kB in intestinal inflammation. Int J Colorectal Dis. 1999;14:18-28.
37. Díaz A, Casaravilla C, Allen JE, Sim RB, Ferreira AM. Understanding the laminated layer of larval Echinococcus II: immunology. Trends Parasitol. 2011;27:264-73. doi:10.1016/j.pt.2011.01.008.
38. Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE. Helminth parasites-masters of regulation. Immunol Rev. 2004;201:89-116.